Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 9.749.386.306.235.12

What is the latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS ?

The latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS is 9.74 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar20259.74
Mar20249.38
Mar20236.30
Mar20226.23
Mar20215.12

How is EV/EBIT of LINCOLN PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2025 9.74
3.84
Mar2024 9.38
48.89
Mar2023 6.3
1.12
Mar2022 6.23
21.68
Mar2021 5.12 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EV/EBIT ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,159.0 Cr 0.1% -7.5% 3.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹474,396.0 Cr 1.8% 5.6% 16.7% Stock Analytics
DIVIS LABORATORIES ₹196,990.0 Cr 0.5% 13.1% 10.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,354.0 Cr -2.7% 5.1% 42.4% Stock Analytics
CIPLA ₹116,705.0 Cr 2.1% -0.6% -4.5% Stock Analytics
DR REDDYS LABORATORIES ₹94,790.0 Cr -4% -17.5% -8.6% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

0.1%

-7.5%

3.3%

SENSEX

-0.9%

-0.4%

-6.1%


You may also like the below Video Courses